Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

miRNAs associated with prostate cancer risk and progression.

Luu HN, Lin HY, Sørensen KD, Ogunwobi OO, Kumar N, Chornokur G, Phelan C, Jones D, Kidd L, Batra J, Yamoah K, Berglund A, Rounbehler RJ, Yang M, Lee SH, Kang N, Kim SJ, Park JY, Di Pietro G.

BMC Urol. 2017 Mar 20;17(1):18. doi: 10.1186/s12894-017-0206-6. Review.

2.

Is p53 Involved in Tissue-Specific Insulin Resistance Formation?

Strycharz J, Drzewoski J, Szemraj J, Sliwinska A.

Oxid Med Cell Longev. 2017;2017:9270549. doi: 10.1155/2017/9270549. Epub 2017 Jan 17. Review.

3.

Cysts of the Iris Pigment Epithelium. What Is New and Interesting? The 2016 Jose Rizal International Medal Lecture.

Shields JA, Shields CL.

Asia Pac J Ophthalmol (Phila). 2017 Jan-Feb;6(1):64-69. doi: 10.22608/APO.201613. Review.

4.

Ghrelin and Breast Cancer: Emerging Roles in Obesity, Estrogen Regulation, and Cancer.

Au CC, Furness JB, Brown KA.

Front Oncol. 2017 Jan 9;6:265. doi: 10.3389/fonc.2016.00265. eCollection 2017 Jan 9. Review.

5.

Clinically Meaningful Use of Blood Tumor Markers in Oncology.

Holdenrieder S, Pagliaro L, Morgenstern D, Dayyani F.

Biomed Res Int. 2016;2016:9795269. doi: 10.1155/2016/9795269. Epub 2016 Nov 30. Review.

6.

Diagnostic imaging of benign and malignant neck masses in children-a pictorial review.

Brown RE, Harave S.

Quant Imaging Med Surg. 2016 Oct;6(5):591-604. Review.

7.

The Challenges of Detecting Circulating Tumor Cells in Sarcoma.

Tellez-Gabriel M, Brown HK, Young R, Heymann MF, Heymann D.

Front Oncol. 2016 Sep 7;6:202. doi: 10.3389/fonc.2016.00202. eCollection 2016 Sep 7. Review.

8.

Does it make sense to target one tumor cell chemotactic factor or its receptor when several chemotactic axes are involved in metastasis of the same cancer?

Ratajczak MZ, Suszynska M, Kucia M.

Clin Transl Med. 2016 Dec;5(1):28. doi: 10.1186/s40169-016-0113-6. Epub 2016 Aug 10. Review.

9.

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.

Lutz MP, Zalcberg JR, Glynne-Jones R, Ruers T, Ducreux M, Arnold D, Aust D, Brown G, Bujko K, Cunningham C, Evrard S, Folprecht G, Gerard JP, Habr-Gama A, Haustermans K, Holm T, Kuhlmann KF, Lordick F, Mentha G, Moehler M, Nagtegaal ID, Pigazzi A, Puciarelli S, Roth A, Rutten H, Schmoll HJ, Sorbye H, Van Cutsem E, Weitz J, Otto F.

Eur J Cancer. 2016 Aug;63:11-24. doi: 10.1016/j.ejca.2016.04.010. Epub 2016 May 30. Review.

10.

Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.

Coleman CN, Higgins GS, Brown JM, Baumann M, Kirsch DG, Willers H, Prasanna PG, Dewhirst MW, Bernhard EJ, Ahmed MM.

Clin Cancer Res. 2016 Jul 1;22(13):3138-47. doi: 10.1158/1078-0432.CCR-16-0069. Epub 2016 May 6. Review.

11.

Perivascular Epithelioid Cell Tumor of the Uterus with Ovarian Involvement: A Case Report and Review of the Literature.

Fitzpatrick M, Pulver T, Klein M, Murugan P, Khalifa M, Amin K.

Am J Case Rep. 2016 May 6;17:309-14. Review.

12.

Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.

Lipsey CC, Harbuzariu A, Daley-Brown D, Gonzalez-Perez RR.

World J Methodol. 2016 Mar 26;6(1):43-55. doi: 10.5662/wjm.v6.i1.43. eCollection 2016 Mar 26. Review.

13.

Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report.

Armstrong TS, Bishof AM, Brown PD, Klein M, Taphoorn MJ, Theodore-Oklota C.

Neuro Oncol. 2016 Mar;18 Suppl 2:ii1-ii12. doi: 10.1093/neuonc/nov267. Review.

14.

Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans.

Batai K, Murphy AB, Nonn L, Kittles RA.

Front Immunol. 2016 Feb 22;7:53. doi: 10.3389/fimmu.2016.00053. eCollection 2016 Feb 22. Review.

15.

Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer.

Casey MC, Sweeney KJ, Brown JA, Kerin MJ.

Int J Cancer. 2016 Jul 1;139(1):12-22. doi: 10.1002/ijc.29985. Epub 2016 Jan 30. Review.

16.

25 Years On: A Retrospective on Migration Inhibitory Factor in Tumor Angiogenesis.

Chesney JA, Mitchell RA.

Mol Med. 2015 Oct 27;21 Suppl 1:S19-24. doi: 10.2119/molmed.2015.00055. Review.

17.

p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis.

Wang X, Simpson ER, Brown KA.

Cancer Res. 2015 Dec 1;75(23):5001-7. doi: 10.1158/0008-5472.CAN-15-0563. Epub 2015 Nov 16. Review. Erratum in: Cancer Res. 2016 Mar 15;76(6):1668.

18.

Oncolytic Replication of E1b-Deleted Adenoviruses.

Cheng PH, Wechman SL, McMasters KM, Zhou HS.

Viruses. 2015 Nov 6;7(11):5767-79. doi: 10.3390/v7112905. Review.

19.

The role of cytokines in the pathophysiology of suicidal behavior.

Ganança L, Oquendo MA, Tyrka AR, Cisneros-Trujillo S, Mann JJ, Sublette ME.

Psychoneuroendocrinology. 2016 Jan;63:296-310. doi: 10.1016/j.psyneuen.2015.10.008. Epub 2015 Oct 19. Review.

20.

Ameloblastoma: A Review of Recent Molecular Pathogenetic Discoveries.

Brown NA, Betz BL.

Biomark Cancer. 2015 Oct 4;7(Suppl 2):19-24. doi: 10.4137/BIC.S29329. eCollection 2015 Oct 4. Review.

Supplemental Content

Loading ...
Support Center